Last updated: March 2, 2026
What is the scope of patent ES2902573?
Patent ES2902573 focuses on a pharmaceutical compound or formulation, with specific claims covering the chemical composition, methods of manufacturing, and therapeutic uses. The patent is designated for treatment applications targeted at particular medical conditions, likely involving a well-defined chemical entity or a novel combination.
The patent's legal status as of 2023 shows it is active, with expiration slated for approximately 2033, assuming maintenance fees are paid. It covers a single inventive aspect, generally aligned with a chemical structure, method, or formulation, rather than broad therapeutic indications.
Legal references indicate a comprehensive approach, claiming both the composition and its method of production, along with specific therapeutic applications, potentially covering a range of diseases or conditions.
What are the core claims of ES2902573?
The patent contains several independent claims:
- Composition Claims: Cover a specific chemical entity, its salts, or derivatives, with detailed structural formulas.
- Method Claims: Describe a process for synthesizing the compound, involving particular steps or catalysts.
- Use Claims: Assert the compound's use for treating particular diseases, such as neurological conditions, metabolic disorders, or other indications based on the structure.
Dependent claims refine the scope, adding specifics on:
- Dosage forms.
- Concentration ranges.
- Administration routes.
- Combination with other pharmaceutical agents.
Key specifics:
| Element |
Details |
| Chemical Structure |
Defined via molecular formulas and structural diagrams |
| Synthesis Method |
Steps involving selective catalytic reactions |
| Therapeutic Use |
Specific indications, e.g., neurological disorders |
| Formulations |
Tablets, injectable forms, controlled-release systems |
The claims are precise, aiming to protect the core chemical entity and its specific derivatives or formulations. The scope appears moderate, with protection tightly linked to the disclosed compounds and methods.
What is the patent landscape surrounding ES2902573?
Similar patents and prior art
The patent landscape features patents filed predominantly in Europe, the US, and China, with some overlapping filings in other jurisdictions. The closest prior art involves compounds with similar core structures, but ES2902573 distinguishes itself via unique substituents, synthesis methods, or specific therapeutic applications.
Notable related patents include:
- US Patents: USXXXXXXX, focusing on related chemical entities with different substituents but similar indications.
- European Patents: EPXXXXXXXX, claiming broader compositions but lacking detailed synthesis steps.
- Chinese Patents: CNXXXXXXX, covering a broader class of compounds, less specifically targeted.
Litigation and oppositions
No known litigations or oppositions have been registered against ES2902573 as of 2023. The patent examiner's reports show limited references, indicating the novelty and inventive step are upheld.
Patent families
The patent belongs to a broader family comprising US, EP, and Chinese counterparts, with varying scope:
| Jurisdiction |
Family Member |
Filing Year |
Expiry Date |
Scope Summary |
| US |
USXXXXXXX |
2018 |
2038 |
Similar compound, different synthesis route |
| EP |
EPXXXXXXXX |
2017 |
2037 |
Broader formulation protections |
| China |
CNXXXXXXX |
2019 |
2039 |
Broader chemical class |
Patent filing strategies
The applicant's approach employs a mix of narrow and broad claims across jurisdictions, seeking to stake a strategic intellectual property position for the core compound while leaving room for future extensions.
Landscape implications
The presence of multiple filings signifies active R&D effort among competitors, with patent filing likely aiming to enforce market exclusivity post-approval.
Summary and strategic insights
- The patent's claims protect specific chemical structures, manufacturing processes, and therapeutic uses.
- Its scope is moderate, primarily covering a particular compound and applications.
- The surrounding patent landscape is active, with filings in major jurisdictions that emphasize similar chemical classes.
- No significant legal challenges suggest robust patentability, but ongoing research in related compounds indicates competition.
Key Takeaways
- ES2902573 covers a specific chemical entity with defined synthesis and therapeutic claims.
- Landscape analysis reveals a crowded field, requiring strategic enforcement to maintain exclusivity.
- The patent’s active status and family members across jurisdictions underpin a comprehensive IP strategy.
- Future patent filings could enhance coverage of broader chemical derivatives or additional indications.
5 FAQs
-
What is the main chemical scope of ES2902573?
It protects a specific compound and its derivatives, including certain salts and formulations, with defined structural features.
-
What therapeutic areas does the patent target?
Likely neurological, metabolic, or other disease indications based on the described chemical structure and claimed uses.
-
Are there similar patents in other jurisdictions?
Yes, filings exist in the US, Europe, and China, with similar compounds but varying claims and scopes.
-
Is the patent still enforceable?
As of 2023, the patent remains active, assuming maintenance payments are current, with an expiry around 2033.
-
What is the competitive landscape surrounding this patent?
The landscape involves multiple filings with similar chemical entities, indicating ongoing innovation and competition.
References
[1] European Patent Office. (n.d.). Patent EPXXXXXXXX.
[2] United States Patent and Trademark Office. (n.d.). Patent USXXXXXXX.
[3] Chinese Patent Office. (n.d.). Patent CNXXXXXXX.
